Company

Azenta, Inc.

Public · AZTA

Azenta is a provider of life sciences solutions including cold-chain sample management, genomic services, automation, and cryogenic storage for pharmaceutical, biotech, academic, and healthcare institutions.

Azenta, Inc. is a publicly traded company. It trades under the ticker AZTA. Leadership tracked by CEOInsider includes Martin D. Madaus (CEO) and Dr. Martin D. Madaus (CEO).

www.azenta.com ↗LinkedIn ↗

Leadership

Current

Recent developments

AI summary of recent coverage

Recent coverage has focused on Azenta's leadership transition, with CEO John Marotta stepping down and Dr. Martin Madaus named as interim CEO effective August 22, 2026, an announcement that coincided with a 12% stock decline. The interim CEO reaffirmed the company's revenue guidance despite the leadership change. Coverage has also touched on broader challenges facing Azenta, including weakness in life science funding and an ongoing securities fraud investigation.

Summarized from the headlines in the sidebar; see each source for the full story.